Natural antibodies to factor VIII are present in the normal antibody repert
oire as other self-reactive antibodies to soluble proteins. The question as
to whether they represent just a chance occurrence linked to the huge dive
rsification of the antibody repertoire or whether these antibodies have an
actual physiological relevance is not entirely settled. Evidence is in favo
r of a role in the maintenance of immune homeostasis, however, namely self-
reactive antibodies are required to maintain the capacity of the immune sys
tem to distinguish self from nonself.
Anti-factor VIII antibodies pose an interesting case in point because they
exhibit the capacity to inhibit the function of factor VIII. Such a propert
y is neutralized at least in part by the production of corresponding anti-i
diotypic antibodies. Normal homeostasis can therefore be viewed as a networ
k of interacting molecules, idiotypes, and anti-idiotypes; disruption of th
is equilibrium leads to the development of autoimmunity.
A question that remains open for the time being is whether this network of
interactions can be modulated in a defined way for the treatment of autoimm
une reactions. This would mean either passive administration of anti-idioty
pic antibodies or active immunization with idiotypes. The former has proved
to be efficient, and the latter has still to be demonstrated. Further, and
probably most importantly, is the question of the possible application of
the idiotypic network concept to the treatment of hemophilia patients produ
cing inhibitors. This essentially requires that an analysis of the anti-fac
tor VIII immune response be carried out at the clonal level. Such work is o
ngoing in our laboratory.